本研究闡述透過藉由開放式創新的商業模式的核心【開放】之應用,同時合併使用商業模式畫布之九宮格模型建構出企業內、外部結合的創新價值,提出企業降低成本與提升營收的策略規劃方向;於製藥產業的領域,是首創成功將商業模式畫布架構的九大項元素交集,透過開放式創新商業模式可以串聯出各個元素間的商業模式策略規劃,闡述更完整的商業模式策略規劃的價值所在。 個案分析F藥品公司在最新穎的凍晶乾燥注射劑技術領域,對合作夥伴採取開放式創新商業模式的策略規劃,提供客戶在商業模式畫布架構下整合的完整服務,對於製藥產業而言是全新完整建構出具確實可行性的新創商業模式,不同於過往設置直屬總經理的創新小組,將智財單位提升至公司策略規劃的層級,在持續運營過程中直接負責增加營收和降低成本二個面向之各項行動方案,達成創造企業新得價值、並且捕獲新的價值的最終目標。
This study illustrates the application of [open] is the core of the business model through open innovation, and the combination of the nine-square grid model of the business model canvas to construct the innovative value of the combination of internal and external enterprises, and proposes strategies for reducing costs and increasing revenue. Planning direction; in the field of the pharmaceutical industry, it is the first to successfully combine the nine elements of the business model canvas architecture. Through the open innovation business model, the business model strategy planning between various elements can be serialized, and the more complete business model strategic planning is elaborated. The value of it. Case Study F Pharmaceuticals has adopted a strategy of open and innovative business model for partners in the field of the most novel frozen crystal dry injection technology, providing customers with a complete service integrated under the business model canvas structure, which is completely new for the pharmaceutical industry. Constructing a new viable business model, which is different from the original innovation team that directly sets up the general manager, upgrades the intellectual property unit to the level of the company's strategic planning, and is directly responsible for increasing revenue and reducing costs in the ongoing operation. The various action plans achieve the ultimate goal of creating new value for the enterprise and capturing new value.